Navigation Links
Northern California Cancer Center's First-of-Its-Kind Research Reveals Low Socioeconomic Status Often Equals Poor Chance of Lymphoma Survival
Date:7/20/2009

Considerably higher risk of follicular lymphoma-related death in poorer neighborhoods may be linked to care required to address waxing and waning progression of disease

FREMONT, Calif., July 20 /PRNewswire-USNewswire/ -- The Northern California Cancer Center (NCCC) recently found that lower socioeconomic status is "significantly associated with substantially poorer survival" of follicular lymphoma in California.

Although survival rates for lymphomas have improved in recent years, not all groups are experiencing improvements. The NCCC team, headed by Theresa Keegan, Ph.D., found that among all patients diagnosed with follicular lymphoma in California, those in poorer neighborhoods had as much as a 37% increased risk of death from the disease, regardless of race/ethnicity, or the stage of their disease when diagnosed. The study results were published in the Journal of Clinical Oncology, June, 2009. NCCC's research is the first to look at socioeconomic levels and survival of this form of cancer.

Follicular lymphoma, the slow-growing, most common type of non-Hodgkin lymphoma, is a cancer of the immune system and white blood cells which affects men and women equally. The cancer involves the body's lymph nodes which fight infection and disease. It begins with an enlargement of the lymph nodes and symptoms can include fever, weight loss, sweating and fatigue. It is called "follicular" lymphoma because lymph nodes seen under microscopes display unusual rounded structures called "follicles."

Follicular lymphoma is known for its waxing and waning course. It may flare up and regress a number of times over years, which would require a continuing care program. The nature of the disease could make it difficult for people who may not be able to acc
'/>"/>

SOURCE Northern California Cancer Center
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Fertility Physicians of Northern California Researchers Test New Forms of Progesterone Medication for Luteal Support During IVF
2. Bad News to Bad Bugs: Northern Antibiotics Develops Novel Polymyxins With Reduced Toxicity
3. Northern California Foot and Ankle Center Santa Rosa Enrolling Patients With Chronic Diabetic Foot Ulcers for Matrix Clinical Research Trial
4. University of California Los Angeles Selects Velos eResearch
5. deCODE Receives California Clinical Laboratory License
6. Global Health Research Foundation Awarded $25,000 Grant From Westly Foundation to Study Asthma in Californias Central Valley
7. California Stem Cell Agency Exaggerated Its Role in Funding Key Research
8. New Conflict of Interest Violations Revealed at California Stem Cell Institute
9. Tezampanel, TorreyPines Therapeutics Lead Compound, Reduced Muscle Spasticity and Rigidity in Preclinical Study Conducted at University of California, San Diego
10. Veto of Californias Condoms in Prisons Bill: "Politics Over Public Health," Says AHF
11. California Legislature Passes Historic HIV Testing Bill (AB 682); AHF Urges Governor to Sign Crucial Lifesaving Legislation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2015)... 2015 Caris Life Sciences®, a leading ... precision medicine, today announced the presentation of data ... Caris Molecular Intelligence®, the company,s panomic comprehensive tumor ... share histological features. In separate presentations at the ... Oncology (ASCO) in Chicago, Ill. ...
(Date:5/29/2015)... -- Hologic, Inc. (NASDAQ: HOLX ) announced today that ... credit agreement consisting of a $1.5 billion senior Term ... Hologic has borrowed $0.175 billion against the new ... Loan to pay off the Company,s previous senior secured ... of $1.69 billion as of March 28, 2015.  As ...
(Date:5/29/2015)... 29, 2015  Excite Medical was established by its ... years, Excite Medical, under the leadership of Mr. ... with a solid track record of providing unparalleled service ... distributor base.  Photo - http://photos.prnewswire.com/prnh/20150529/219412 ... has been possible, in large part, due to ...
Breaking Medicine Technology:Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 2Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 3Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 4Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 5Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 6Hologic Enters into Five-Year Secured Credit Agreement 2Hologic Enters into Five-Year Secured Credit Agreement 3
... The Dr. Paul Janssen Award for Biomedical Research ... prestigious award recognizes individuals whose scientific research has ... transformational contributions toward the improvement of human health. ... will be accepted until February 15, 2011, for ...
... Samplify Systems, Inc., a leading provider of technology, ... pleased to announce that its AutoFocus™ beamforming technology ... Design Magazine,s Best Electronic Design award for ... AutoFocus™ beamforming technology currently appear in Electronic ...
Cached Medicine Technology:Dr. Paul Janssen Award for Biomedical Research Issues Call for Nominations 2Dr. Paul Janssen Award for Biomedical Research Issues Call for Nominations 3Samplify's AutoFocus™ Beamforming Technology Awarded Electronic Design's 'Best of 2010' 2
(Date:5/30/2015)... May 30, 2015 AVT, the world ... assurance, is joining forces with leading proofing solutions provider ... the worldwide printing market. , Under the ... software engine for its offline inspection solutions, which are ... industry and its varying production workflow setups and printing ...
(Date:5/30/2015)... Clarkston, Metamora, Michigan (PRWEB) May 30, 2015 ... simple procedure to lighten or stop periods, without ... hysterectomy. This procedure can reduce or stop menstrual bleeding ... of the uterus (the part that causes the bleeding), ... 10 million women suffer from heavy menstrual bleeding. ...
(Date:5/30/2015)... York (PRWEB) May 30, 2015 ... $100 million in punitive and compensatory damages to ... who suffered serious complications following implantation of the ... a verdict rendered on May 28th in Delaware ... in compensatory damages after the jury found that ...
(Date:5/30/2015)... Nicole Blodgett, Vice President of ... (DIA) designation to further her expertise in the ... for insurance advisors, health care professionals, and financial ... expertise associated with the risk and the cost ... only the latest accomplishment in Nicole's journey with ...
(Date:5/30/2015)... May 30, 2015 Wixom, Michigan: Proof. Pest Control, ... has added a new twist to its robust line of ... services are used for general pest management. , ... Draper, proof.’s Wixom Branch Manager. “The average person cringes when ... in dealing with problems that most people don’t even want ...
Breaking Medicine News(10 mins):Health News:AVT and Global Vision Collaborate to Offer Cutting-edge Offline Inspection Solutions for Printing Industry 2Health News:AVT and Global Vision Collaborate to Offer Cutting-edge Offline Inspection Solutions for Printing Industry 3Health News:Women's Excellence Now Provides NovaSure Treatment 2Health News:Boston Scientific Transvaginal Mesh Lawsuit Trial Ends With $100 Million Verdict 2Health News:Boston Scientific Transvaginal Mesh Lawsuit Trial Ends With $100 Million Verdict 3Health News:Boston Scientific Transvaginal Mesh Lawsuit Trial Ends With $100 Million Verdict 4Health News:Secura Consultants Expands Disability Insurance Expertise 2Health News:Proof. Pest Control-Now Offering 100% Organic Pest Control in Southeast Michigan 2
... many health,recommendations in the media these days that it,s often ... make for better,health in the year ahead. ISSA polled their ... for their top,recommendations for the 10 best things their clients ... are the results of that survey:, 1 ...
... SMTS ) will release its financial results for the ... the opening of the market on,Wednesday, January 23, 2008. ... a conference call that will be webcast live at ... call, Bruce Barrett, Somanetics, president and chief,executive officer, and ...
... people cut down on excessive alcohol use , FRIDAY, Jan. ... dangers of alcohol abuse by an emergency room doctor or ... three drinks a week, new research shows. , Researchers trained ... tool, then applied it to almost 7,800 emergency patients in ...
... Inc. (NYSE:,DVA) announced today that it and Southwest ... to provide dialysis and vascular,access services, as well ... greater Phoenix area. The partnership will own and ... provide patients with,access to all available treatment modalities. ...
... precise cancer treatments ... form of volumetric arc therapy, PALO ALTO, Calif., ... has received FDA 510(k) clearances for its RapidArc(TM),radiotherapy technology, ... intensity-modulated radiation therapy (IMRT) two to,eight times faster and ...
... Pharmaceuticals,Inc. (NYSE: BRL ) today announced that ... from the U.S. Food and Drug Administration,(FDA) for ... hydrochloride) Tablets, 1mg (eq to 1 mg base). ... Roche,s patent on,December 28, 2007, and plans to ...
Cached Medicine News:Health News:International Sports Sciences Association's Ten Best Resolutions for Better Health in 2008 2Health News:Somanetics Corporation to Release Fourth Quarter and Fiscal 2007 Financial Results and Host Conference Call January 23, 2008 2Health News:Brief Chat With ER Docs Can Curb Problem Drinking 2Health News:Varian Medical Systems Receives FDA 510(k) Clearance for RapidArc(TM) Radiotherapy Technology 2Health News:Varian Medical Systems Receives FDA 510(k) Clearance for RapidArc(TM) Radiotherapy Technology 3Health News:Varian Medical Systems Receives FDA 510(k) Clearance for RapidArc(TM) Radiotherapy Technology 4Health News:Barr Receives Approval for Generic KYTRIL(R) Tablets, 1mg (Base) 2Health News:Barr Receives Approval for Generic KYTRIL(R) Tablets, 1mg (Base) 3
The Vitatron Excellence + lead series are endocardial leads providing excellent handling and optimal pacing characteristics....
... Vitatron Impulse II lead series are ... to extend the longevity of the ... pacing. The high impedance of the ... small electrode surface, combined with the ...
The Vitatron Slimtine S lead series are endocardial leads with an excellent history of reliability and optimal handling en pacing performance....
The Guidant Fineline II Sterox Atrial J is a steroid-eluting pacing lead designed for permanent implantation for either atrial or ventricular applications....
Medicine Products: